Sandra Kurtin, PhD, ANP-C, AOCN^®, is a hematology/oncology Nurse Practitioner at the University of Arizona Cancer Center, a National Cancer Institute–designated comprehensive cancer center. She is also an Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona.

Dr. Kurtin has worked in oncology nursing practice for 37 years, focusing on both benign and malignant hematologic disorders. Her particular interest is older cancer survivors. She is a founding board member and current President of the Advanced Practitioner Society for Hematology and Oncology (APSHO); is Treasurer and Executive Board Member for the MDS Foundation; and is an active member of ASH, ASCO, ONS, and the AANP. She is an Associate Editor for JADPRO and The Oncology Nurse. Her research has been widely published and she lectures nationally and internationally.

Dr. Kurtin obtained her Bachelor of Science degree in Nursing with high distinction, a Master of Science in Oncology Nursing, postgraduate certifications in both geriatric and adult practice, and a PhD in nursing all from the University of Arizona.

Frances Blevins, PA-C, is a board-certified Physician Assistant. She joined the Solomont Center for Hematology and Medical Oncology at Boston Medical Center (BMC) in 2015 and works with the hematology team. Ms. Blevins is an Assistant Professor at Boston University (BU) School of Medicine and a preceptor for PA Hematology/Oncology clinical rotations in BU’s Physician Assistant Program. She works in both malignant and benign hematology. Her special interest is the care of patients with chronic idiopathic thrombocytopenia, multiple myeloma, and lymphoma.

She is a member of national organizations including ASH, NCCN, and the American Academy of Physician Assistants. She serves on the Advanced Practice Provider Council of Boston Medical Center. Her research with colleagues from BMC has been presented at the ASH annual meeting and published in Blood and Pharmacy Times.

Ms. Blevins graduated from the Tufts University School of Medicine Physician Assistant program, from which she obtained her Master of Medical Science degree.

Susan M. Carson, RN, MSN, CPNP, is the Nurse Practitioner for the Thalassemia and Chronic Transfusion Program and the Red Cell Program at Children’s Hospital Los Angeles (CHLA) Institute for Cancer and Blood Diseases. She has served in this role since 2002 but joined CHLA in 1998. At CHLA, she is chair and organizer of the Annual NP Research Symposium, an event she founded in 2013. Since 2007, she has been an Associate Clinical Professor of Nursing at the UCLA School of Nursing.

Prior to joining CHLA, Ms. Carson worked at the Toronto Hospital for Sick Children, where she initiated the formation of the International Thalassemia Nurse’s Network. An internationally known speaker on thalassemia, sickle cell disease, and iron overload, she has presented at annual meetings of ASH and the New York Academy of Sciences Cooley’s Anemia symposia, as well as conferences and workshops in the US and internationally. Her work has been published in prominent medical journals.

Ms. Carson received her Bachelor of Science in Nursing degree from the University of Toronto and her MSN and CPNP degrees from UCLA School of Nursing.

Since 1987, Jennifer Donkin, PNP, DNP, has worked as a PNP and Care Manager in the Hemostasis and Thrombosis Center at Children’s Hospital Los Angeles (CHLA) Institute for Cancer and Blood Diseases. She began her career in 1978 as a staff RN at CHLA and was certified as a PNP in 1986. Besides patient care, she educates and mentors nursing and NP students; interns, residents, and fellows; and visiting healthcare professionals.

Dr. Donkin has long been fascinated by bleeding and thrombosis disorders. She is co-investigator on several pharmaceutical trials and is currently PI for a trial designed to evaluate obesity within the hemophilia population. Her work has been published in the Journal of Pediatric Hematology/Oncology. Since 2011, through a twinning program with CHLA, she has assisted in development of a Hemostasis Program in Arequipa, Peru, for underserved patients.

Dr. Donkin received her BSN from Mount St. Mary’s College, Los Angeles and her PNP from California State University, Long Beach, where she was also a master’s degree candidate. In 2020, she received her DNP from the University of Arizona.

David M. Hughes, PharmD, BCOP, is a board-certified Clinical Pharmacy Specialist in the outpatient hematology/oncology clinic at Boston Medical Center (BMC). He is an Assistant Professor of Medicine at Boston University School of Medicine.

Dr. Hughes has participated in clinical studies of oncologic and hematologic malignancies, and he is especially interested in multiple myeloma, light chain amyloidosis, and immune thrombocytopenia. He has presented at national conferences including SABCS and ASH, and his work has been published in peer-reviewed hematology and oncology journals. In 2019, he participated in a 10-day medical mission trip to Honduras that provided medical care to more than 500 patients and administered more than 2,000 prescriptions.

Dr. Hughes received his PharmD from Albany College of Pharmacy and Health Sciences. He undertook his post-graduate training at the University of California and at BMC, which named him Resident of the Year in 2018.

Natasha L. Johnson, MSN, APRN, AOCNP^®, is a Nurse Practitioner in the Malignant Hematology department of H. Lee Moffitt Cancer Center and Research Institute. She has worked as an AOCNP at Moffitt since 2013. From 2012 to 2013, as part of her APRN Practicum experience at Moffitt, she worked in inpatient pain management and palliative care, and then in outpatient clinics in medical oncology and malignant hematology.

Ms. Johnson is especially interested in myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. At Moffitt she also cares for patients with rare bone marrow failure disorders. She is a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO) and has served on the MDS Foundation International Nurse Leadership Board since February 2019. Her work has been presented at many medical meetings and published in CJON.

Ms. Johnson received both her BSN and MSN degrees from the University of South Florida.

Sara M. Tinsley, PhD, APRN, AOCN^®, is a nurse practitioner in the Malignant Hematology department of H. Lee Moffitt Cancer Center and Research Institute. She began her career at Moffitt in 1990, as a blood and bone marrow transplant RN.

She specializes in the care of AML, MDS, aplastic anemia, and other bone marrow failure syndromes. At Moffitt, she has participated in numerous clinical trials, recently serving as PI in research evaluating QoL decision-making in AML and MDS.

Her work has been presented at ASH, ONS, SOHO, and ASCO’s Quality Care Symposium; and published in medical journals including JADPRO, Clinical Lymphoma, Myeloma & Leukemia, Clinical Cancer Research, American Journal of Hematology, and CJON. She serves on the peer review boards of JADPRO and CJON. She is a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO), ASH, ASCO, ONS, and APOS.

Dr. Tinsley received her BS, MS, and PhD degrees in nursing from the University of South Florida (USF). She has worked as a courtesy instructor and as an assistant professor at USF for several years.

As the Head of Research for the National Hemophilia Foundation (NHF), Dr. Witkop leads the NHF’s research initiatives, including their most recent community-powered registry, Community Voices in Research (CVR). She is a past recipient of the ANCC Nurse of the Year Award for Transformational Leadership and an ATHN/HRSA Demonstration Project of National Significance Grantee with the project, “Evaluating a Nurse Practitioner Medically Led Hemophilia Treatment Center in Comparison to a Physician Medically Led Hemophilia Treatment Center.”

With extensive experience and research in pain management, Dr. Witkop has been the principal investigator or co-investigator for multiple hemophilia pain research studies, including the National Pain Study and the IMPACT Quality of Life Studies. She has published and lectured extensively.

Dr. Witkop received her BSN degree from Ferris State University, her MSN degree from Grand Valley State University, and her DNP from Oakland University, all in Michigan.

Jacquelyn Keegan has worked as a Nurse Practitioner in the Hemostasis and Thrombosis Center of Children’s Hospital Los Angeles (CHLA) since 2014. From 2012 to 2014, she worked at CHLA as a registered nurse in the inpatient hematology/oncology unit.

Prior to joining CHLA in 2012, Ms. Keegan worked for 6 years as a registered nurse in the inpatient hematology/oncology/bone marrow transplant unit at Columbia New York-Presbyterian Hospital, where she spearheaded the NACHRI (National Association of Children’s Hospital and Related Institutions) collaborative within the hematology/oncology unit.

She has presented on topics related to coagulation and thrombosis at regional conferences and national meetings, including the Association of Pediatric Hematology and Oncology Nurses (APHON).

She has been involved in multiple clinical trials of treatments for patients with hemophilia A, including as co-investigator of a multicenter COVID thrombosis study and principal investigator in the evidence-based practice study Project CLOT (Comprehensive Learning Outcomes for Thrombosis).

Ms. Keegan received her BSN degree from Seton Hall University in South Orange, New Jersey, and her MSN degree from New York University.

Anne Nord, MSN, FNP-C, is a nurse practitioner in the Division of Hematology and a nurse navigator for the PASSAGES Hematology Transition Program at the Children’s Hospital Los Angeles (CHLA) Center for Hematology, Oncology, and Blood and Marrow Transplantation. She began her nursing career at CHLA in 1987.

Ms. Nord moved to New Mexico in 1990 where she was first employed as a nursing instructor in a small town and eventually worked as a Clinical Research Nurse Coordinator in the Department of Obstetrics/Gynecology and Surgery at the University of New Mexico, Albuquerque. In 1998 she moved back to Los Angeles and worked in the Skin Cancer and Melanoma Clinic at the John Wayne Cancer Institute.

In 1999 she rejoined CHLA, again providing direct outpatient care in hematology/oncology and working as a research nurse coordinator for clinical trials in the Division of Hematology until she obtained her MSN degree.

Ms. Nord received her BSN degree from Mount St. Mary’s College, Los Angeles, and her MSN degree and FNP certification from Azusa Pacific University School of Nursing, in Azusa, California.